We are now recruiting at all levels! Please see our job postings for a post-doctoral fellow, a research technician to study tumor evolution, a research technician to study tumor microenvironment, and a research technician to study novel T cell therapies for ALK lung cancer, and a research technician for our model development team. For more information, contact us.
We say farewell to Aya & Wafa. Aya will be at the University of Tsukuba as a faculty member of medicine and Wafa will be attending Harvard Medical school as a graduate student! Best wishes to you in your future endeavors – we will miss you!
Our paper on mechanisms of resistance crizotinib and lorlatinib in ROS1 fusion-positive lung cancer is now available in Clinical Cancer Research. A true translational team effort!
Lin JJ*, Choudhury NJ*, Yoda S*, Zhu VW, Johnson TW, Sakhtemani R, Dagogo-Jack I, Digumarthy SR, Lee C, Do A, Peterson J, Prutisto-Chang K, Malik W, Hubbeling HG, Langenbucher A, Schoenfeld AJ, Falcon CJ, Temel JS, Sequist LV, Yeap BY, Lennerz JK, Shaw AT, Lawrence MS, Ou SI, Hata AN*, Drilon A*, Gainor JF*. Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer. Clin Cancer Res. 2021 Mar 8. doi: 10.1158/1078-0432.CCR-21-0032. Epub ahead of print. PMID: 33685866.
Welcome to Farrah Wakefield who joins our group as a research technician on the model development team.
